Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
21,335 total articles
GT Biopharma reported Q1 2026 financial results highlighting ongoing Phase 1 trials for GTB-3650 in hematologic malignancies and GTB-5550 in multiple solid tumor types. The company has approximately $9 million in cash, expected to fund operations through Q4 2026. Despite increased SG&A expenses leading to a larger net loss compared to last year, th…
Lifeward Ltd. announced its Q1 2026 financial results, highlighting the successful closing of its acquisition of Oratech alongside a $10 million financing. The acquisition adds $6.5 million in cash and advances Lifeward's Protein Oral Delivery platform, including the lead asset ORMD-0801 oral insulin set for Phase 2 trials. The company also acquire…
Galectin Therapeutics disclosed its Q1 2026 financial results, highlighting ongoing advancement of its lead drug belapectin in the NAVIGATE Phase 2b/3 trial for patients with MASH cirrhosis and portal hypertension. The company reported promising biomarker and liver stiffness data supporting belapectin's potential to reduce fibrosis progression. It …
Globavend Holdings Limited, a US-listed e-commerce logistics provider, has agreed to acquire a 70% stake in Loomi Entertainment Group, a digital entertainment company specializing in AI-powered short-form video content aimed at Southeast Asian audiences. This strategic move marks Globavend's entry into the digital entertainment sector to diversify …
Immuneering Corporation announced strong Phase 2a clinical data for its pancreatic cancer drug candidate atebimetinib combined with chemotherapy, which will be presented at the 2026 ASCO Annual Meeting. The pivotal Phase 3 MAPKeeper 301 trial is now recruiting with first dosing on track for mid-2026. Financially, the company ended Q1 2026 with $198…
Bread Financial Holdings, Inc. provided a performance update for April 2026, reporting a 2.0% year-over-year increase in average credit card and other loans. The company noted improvements with net principal losses decreasing to $105 million and the net principal loss rate dropping to 7.09%, alongside a delinquency rate reduction to 5.34%. These fi…
Phillips Edison & Company, a leading owner and operator of grocery-anchored neighborhood shopping centers, has appointed industry veteran Dan Sutherland as Vice President of Acquisitions for the West region. With over 20 years of experience and a strong track record in retail real estate transactions, Sutherland will focus on sourcing and executing…
LM Funding America, a US-based Bitcoin treasury and mining company, reported first quarter 2026 results with record energized hashrate and highest monthly Bitcoin production in company history. Despite mining increased Bitcoin volumes, total revenue fell 11.1% year-over-year due to declining Bitcoin prices. The company incurred a significant net lo…
BriaCell Therapeutics announces the development of Bria-OVA+, a next-generation personalized immunotherapy targeting ovarian cancer, building on their Phase 2 success in metastatic breast cancer. The candidate leverages an enhanced immune-stimulating cell-based platform, aiming to address the significant unmet medical need in ovarian cancer, the de…
Annovis Bio reports strong progress in its Phase 3 Alzheimer's disease trial with 85% patient enrollment and initiation of a Parkinson’s disease open-label extension study at 40% enrollment. The company anticipates NDA submissions for buntanetap as a symptomatic treatment in early 2027 and as a disease-modifying therapy in early 2028. Financially, …
Creative Realities, Inc. announced its fiscal 2026 first quarter results showing a significant year-over-year revenue increase to $16.3 million, driven largely by the acquisition of Cineplex Digital Media (CDM). Despite revenue growth, the company reported an operating loss of $6.2 million and a net loss attributable to common stockholders of $7.9 …
MiNK Therapeutics reported Q1 2026 financial results and highlighted progress on its off-the-shelf invariant natural killer T cell therapy, agenT-797, which has entered a randomized Phase 2 trial targeting severe acute lung injury and critical illness. The trial aims to address a significant unmet need in acute respiratory distress syndrome (ARDS),…
RenX Enterprises Corp. announced its Q1 2026 results, showcasing a 20.5% quarter-over-quarter revenue increase to $3.96 million. The Logistics segment achieved positive operating and net income, while the Biomass Recycling segment saw a 44% increase in material sales and introduced a new land-clearing service. The upgraded Myakka City processing pl…
Palvella Therapeutics announced promising data from its Phase 2 TOIVA trial evaluating QTORIN™ rapamycin for cutaneous venous malformations. The trial showed statistically significant improvements in bleeding and patient satisfaction after 12 weeks of treatment, highlighting QTORIN's potential to become the first FDA-approved therapy for this rare …
Edible Garden AG reported strong first quarter 2026 results with a 22.9% revenue increase driven by broad growth in cut herbs, vitamins, supplements, and branded condiments. The company is advancing its strategic evolution into a clean-label consumer packaged goods and ready-to-drink (RTD) nutrition platform, highlighted by expansion into over 6,00…
Profusa, Inc., a digital health company specializing in tissue-integrated biosensors, announced it has transferred its stock listing to the Nasdaq Capital Market effective May 15, 2026. This move aligns with previously disclosed plans to meet Nasdaq's bid price and stockholders' equity requirements to maintain compliance and listing status. Profusa…
Super League Enterprise, Inc. announced Q1 2026 financial results showing gross revenue growth from $2.7 million to $3.0 million year-over-year and an improvement in gross margin from 32% to 36%. The company's cash-based EBITDA improved 11% year-over-year, and it ended the quarter with $11.4 million in cash and investments. The recent acquisition o…
SOLOWIN HOLDINGS (NASDAQ: AXG), through its stablecoin issuer AX Coin, has signed a non-binding MOU with Gulf-based fintech INFINIOS to collaborate on regulated wallet infrastructure and digital payment solutions to accelerate stablecoin adoption. The partnership will integrate AX Coin into INFINIOS' payments infrastructure, enabling custodial and …
JOYY Inc., a global technology company listed on NASDAQ, announced it will release its first quarter 2026 financial results on May 25, 2026, followed by a management earnings conference call. The event will include a webcast and telephonic replay options for investors and stakeholders.
PMGC Holdings Inc. reported strong Q1 2026 results with total assets exceeding $26 million, a 102% increase from year-end 2025. Revenue for the quarter was approximately $682,000, surpassing the full-year 2025 revenue in a single quarter, fueled by recent acquisitions including SVM Machining and A&B Aerospace. The company also formed NorthStrive De…
Instil Bio, a Nasdaq-listed biotech company, announced its Q1 2026 financial results showing a significant reduction in net loss compared to the previous year, a stable cash position expected to fund operations beyond 2027, and an ongoing strategic evaluation of acquisitions and in-licensing opportunities to expand its therapeutic pipeline.
Kymera Therapeutics presented new clinical data at the SID and ATS meetings demonstrating that KT-621, a first-in-class oral STAT6 degrader, shows robust target engagement, reduction of Type 2 inflammatory biomarkers, and initial clinical activity in atopic dermatitis and asthma. Phase 2b trials are ongoing with data expected by mid and late 2027, …
CECO Environmental Corp. and Thermon Group Holdings, Inc. announced that Thermon stockholders must elect their preferred form of merger consideration by May 22, 2026, ahead of the expected closing of CECO's acquisition of Thermon on June 1, 2026. Thermon shareholders can choose from stock, a combination of stock and cash, or cash consideration. The…
Nutriband Inc. and its subsidiary Active Intelligence will showcase an expanding portfolio of AI-driven wellness and recovery products, including new launches like AI Performance Tape, AI Energy Patches, and AI Sleep solutions, at the upcoming ECRM conference in June 2026. The company plans meetings with major retailers such as Walmart, Walgreens, …
Traws Pharma, a clinical-stage biopharmaceutical company, announced a private financing deal raising up to $60 million to support operations through Q1 2027, while advancing its lead antiviral candidate tivoxavir marboxil (TXM) into a human influenza challenge trial. The company is also developing a potential therapy for hantavirus infections. Q1 f…
